Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at New York-based Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%.
Published by SCIENCE TRANSLATIONAL MEDICINE on March 23, 2022, these researchers wrote, ‘immunotherapy has been of little use at treating highly aggressive pancreatic ductal adenocarcinoma (PDAC) due to its immunosuppressive tumor microenvironment.’
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
